FDA Approves Therapy for Cerebral Folate Deficiency - Top-Institutions - MDSpire

FDA Approves Therapy for Cerebral Folate Deficiency

Decision addresses a rare neurologic disorder linked to folate transport impairment.

  • By

  • Kathryn Wighton

  • March 10, 2026

  • 2 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Boston Children's Hospital
    Boston Children's Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Genetics
    • Metabolic Disorders

  • #2

    National Institutes of Health (NIH) - National Institute of Neurological Disorders and Stroke (NINDS)
    National Institutes of Health (NIH) - National Institute of Neurological Disorders and Stroke (NINDS)

    Bethesda, MD

    Key Differentiators

    • Neurology
    • Genetics
    • Rare Diseases

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Genetics
    • Metabolic Disorders

  • #4

    Children's National Hospital
    Children's National Hospital

    Washington, DC

    Key Differentiators

    • Pediatric Neurology
    • Genetics
    • Rare Diseases

Original Source(s)

FDA Approves Therapy for Cerebral Folate Deficiency

  • by Kathryn Wighton

  • March 10, 2026

Related Content

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Online Program Eases Pediatric Trauma Stress

Randomized trial evaluated therapist-assisted intervention among pediatric patients with persistent symptoms 1 month following trauma

CGRP Therapies May Reduce Migraine Days

Systematic review found high-certainty evidence for several calcitonin gene–related peptide–targeted therapies.